Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
The operating margin is 0.00% as of the fiscal period ended Tuesday, June 30, 2026.
Reported quarterly operating margin; no daily interpolation. Q2 FY2026 (2026-06-30): 0.00%.
OPERATING MARGIN
0.00%
OPERATING MARGIN AVG TTM
0.00%
OPERATING MARGIN AVG 3Y
0.00%
OPERATING MARGIN AVG 5Y
0.00%
OPERATING MARGIN AVG 10Y
N/A
OPERATING MARGIN AVG 15Y
N/A
OPERATING MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.00%
median of 744 covered companies
CURRENT VS SECTOR MEDIAN
N/A
vs the sector median at left
Greenwich LifeSciences, Inc.
Market Cap
$242.34M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$243.62M
Operating Margin
N/A
TTM Avg
-7.18%
3Y Avg
-10.59%
5Y Avg
-10.29%
Market Cap
$241.69M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$244.33M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$246.15M
Operating Margin
31.45%
TTM Avg
15.72%
3Y Avg
41.80%
5Y Avg
-775.63%
Market Cap
$244.52M
Operating Margin
-103.99%
TTM Avg
-400.39%
3Y Avg
-200.20%
5Y Avg
-133.47%
Market Cap
$240.02M
Operating Margin
-1488.31%
TTM Avg
-4815.32%
3Y Avg
-6115.40%
5Y Avg
-4078.06%
Market Cap
$239.90M
Operating Margin
9.95%
TTM Avg
-10.78%
3Y Avg
-18.24%
5Y Avg
-54.36%
Market Cap
$238.61M
Operating Margin
-164525.50%
TTM Avg
-98218.45%
3Y Avg
-66780.63%
5Y Avg
-44520.42%
| NAME | MARKET CAP | OPERATING MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Greenwich LifeSciences, Inc. (GLSI) | $242.34M | 0.00% | 0.00% | 0.00% | 0.00% |
| Lifecore Biomedical, Inc. (LFCR)vs › | $243.62M | N/A | -7.18% | -10.59% | -10.29% |
| Galectin Therapeutics Inc. (GALT)vs › | $241.69M | 0.00% | 0.00% | 0.00% | 0.00% |
| Nautilus Biotechnolgy, Inc. (NAUT)vs › | $244.33M | 0.00% | 0.00% | 0.00% | 0.00% |
| Q32 Bio Inc. (QTTB)vs › | $246.15M | 31.45% | 15.72% | 41.80% | -775.63% |
| Invivyd, Inc. (IVVD)vs › | $244.52M | -103.99% | -400.39% | -200.20% | -133.47% |
| CAMP4 Therapeutics Corporation (CAMP)vs › | $240.02M | -1488.31% | -4815.32% | -6115.40% | -4078.06% |
| Akebia Therapeutics, Inc. (AKBA)vs › | $239.90M | 9.95% | -10.78% | -18.24% | -54.36% |
| InflaRx N.V. (IFRX)vs › | $238.61M | -164525.50% | -98218.45% | -66780.63% | -44520.42% |
| SIGA Technologies, Inc. (SIGA)vs › | $238.23M | 25.05% | 37.75% | 43.45% | 51.35% |
Gross Margin
0.0%
Operating Margin
0.0%
Operating Margin = Operating Income / Revenue
Operating margin is the percentage of revenue remaining after operating expenses, reflecting operating efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | OPERATING MARGIN |
|---|---|
| 2026-06-30 | 0.00% |
| 2026-03-31 | 0.00% |
| 2025-12-31 | 0.00% |
| 2025-09-30 | 0.00% |
| 2025-06-30 | 0.00% |
| 2025-03-31 | 0.00% |
| 2024-12-31 | 0.00% |
| 2024-09-30 | 0.00% |
| 2024-06-30 | 0.00% |
| 2024-03-31 | 0.00% |
| 2023-12-31 | 0.00% |
| 2023-09-30 | 0.00% |
| 2023-06-30 | 0.00% |
| 2023-03-31 | 0.00% |
| 2022-12-31 | 0.00% |
| 2022-09-30 | 0.00% |
| 2022-06-30 | 0.00% |
| 2022-03-31 | 0.00% |
| 2021-12-31 | 0.00% |
| 2021-09-30 | 0.00% |
| 2021-06-30 | 0.00% |
| 2021-03-31 | 0.00% |
| 2020-12-31 | 0.00% |
| 2020-09-30 | 0.00% |
| 2020-06-30 | 0.00% |
| 2020-03-31 | 0.00% |
| 2019-12-31 | 0.00% |
| 2019-09-30 | 0.00% |
| 2019-06-30 | 0.00% |
| 2019-03-31 | 0.00% |
| 2018-12-31 | 0.00% |
